Raday Gilead (CIK 2113137) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-22). Recent activity: Sell RDHL (15.7M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-22 | RedHill Biopharma Ltd. (RDHL) | Chief Operating Officer | Sell | 15.7M | $0 |
Source: SEC Form 4 filings · as of 2026-04-22